Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Critical Care Medicine
|
August 1, 1992
Addition of alinidine, a specific bradycardic agent, to dobutamine in a canine model of endotoxic shock
J C Preiser, D Moulart, J L Vincent
Circulatory Shock
|
March 1, 1990
Dichloroacetate administration in the treatment of endotoxin shock
J C Preiser, D Moulart, J L Vincent
Minerva Anestesiologica
|
May 5, 2011
Do use ScvO2 and O2ERe as therapeutical goals
A Donati, P Pelaia, P Pietropaoli, et al.
BMJ Open
|
November 5, 2020
Intensive care units follow-up: a scoping review protocol
Danielle Prevedello, Marco Fiore, Jacques Creteur, et al.
Revue Medicale De Bruxelles
|
May 1, 1993
[Should bicarbonates still be administered in lactic acidosis?]
J L Vincent, S Blecic, J C Preiser, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 14, 2000
Effects of nitric oxide in septic shock
J L Vincent, H Zhang, C Szabo, et al.
Circulatory Shock
|
December 1, 1991
Administration of the calcium agonist BAY K 8644 in endotoxic shock
J C Preiser, D Moulart, B Cosyns, et al.
Revue Medicale De Liege
|
April 8, 2021
[Advocacy for an improved training in clinical nutrition during the medical cursus]
J P Thissen, A Boucquiau, N Paquot, et al.
Journal of Medicinal Food
|
March 14, 2009
Isoflavone-mediated inhibition of tyrosine kinase: a novel antiinflammatory approach
A L Salzman, J C Preiser, K D Setchell, et al.
Intensive Care Medicine
|
November 23, 2000
Hemodynamic responses to successful weaning from mechanical ventilation after cardiovascular surgery
D De Backer, P El Haddad, J C Preiser, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Critical Care Medicine
|
August 1, 1992
Addition of alinidine, a specific bradycardic agent, to dobutamine in a canine model of endotoxic shock
J C Preiser, D Moulart, J L Vincent
Circulatory Shock
|
March 1, 1990
Dichloroacetate administration in the treatment of endotoxin shock
J C Preiser, D Moulart, J L Vincent
Minerva Anestesiologica
|
May 5, 2011
Do use ScvO2 and O2ERe as therapeutical goals
A Donati, P Pelaia, P Pietropaoli, et al.
BMJ Open
|
November 5, 2020
Intensive care units follow-up: a scoping review protocol
Danielle Prevedello, Marco Fiore, Jacques Creteur, et al.
Revue Medicale De Bruxelles
|
May 1, 1993
[Should bicarbonates still be administered in lactic acidosis?]
J L Vincent, S Blecic, J C Preiser, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 14, 2000
Effects of nitric oxide in septic shock
J L Vincent, H Zhang, C Szabo, et al.
Circulatory Shock
|
December 1, 1991
Administration of the calcium agonist BAY K 8644 in endotoxic shock
J C Preiser, D Moulart, B Cosyns, et al.
Revue Medicale De Liege
|
April 8, 2021
[Advocacy for an improved training in clinical nutrition during the medical cursus]
J P Thissen, A Boucquiau, N Paquot, et al.
Journal of Medicinal Food
|
March 14, 2009
Isoflavone-mediated inhibition of tyrosine kinase: a novel antiinflammatory approach
A L Salzman, J C Preiser, K D Setchell, et al.
Intensive Care Medicine
|
November 23, 2000
Hemodynamic responses to successful weaning from mechanical ventilation after cardiovascular surgery
D De Backer, P El Haddad, J C Preiser, et al.
Page
of 6